sunitinib accord
accord healthcare s.l.u. - szunitinibbel - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - daganatellenes szerek - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
sunitinib pharmascience 12,5 mg kemény kapszula
pharmascience international ltd. - szunitinibbel -
sunitinib pharmascience 25 mg kemény kapszula
pharmascience international ltd. - szunitinibbel -
sunitinib pharmascience 37,5 mg kemény kapszula
pharmascience international ltd. - szunitinibbel -
sunitinib pharmascience 50 mg kemény kapszula
pharmascience international ltd. - szunitinibbel -
sunitinib teva 25 mg kemény kapszula
teva b.v. - szunitinibbel -
sunitinib g.l. pharma 12,5 mg kemény kapszula
g.l. pharma gmbh - szunitinibbel -
sunitinib g.l. pharma 25 mg kemény kapszula
g.l. pharma gmbh - szunitinibbel -
sunitinib g.l. pharma 50 mg kemény kapszula
g.l. pharma gmbh - szunitinibbel -
sunitinib krka 12,5 mg kemény kapszula
krka d.d., - szunitinibbel -